North America IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: July 09, 2025 Report Code: GDME20422CRDB-ST

Select Item

GlobalData’s “North America IVD Analyzers Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America IVD Analyzers market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers, Clinical Chemistry Analyzers, Integrated Clinical Chemistry & Immunochemistry Analyzers, Immunochemistry Analyzers and Next Generation Sequencers

The North America IVD Analyzers Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for IVD Analyzers Market.
• Global corporate-level profiles of key companies operating within the North America IVD Analyzers Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America IVD Analyzers is segmented as follows –

• Hematology Analyzers

• Polymerase Chain Reaction (PCR) Systems

• Point of Care (POC) Analyzers

• Clinical Chemistry Analyzers

• Integrated Clinical Chemistry & Immunochemistry Analyzers

• Immunochemistry Analyzers

• Next Generation Sequencers

Reasons to Buy

The North America IVD Analyzers Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 8

2 Introduction 9

2.1 What Is This Report About? 9

2.2 IVD Analyzers Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 IVD Analyzers Market, North America 14

3.1 IVD Analyzers Market, North America, Revenue ($m), 2018-2033 14

3.2 IVD Analyzers Market, North America, Revenue ($m), 2018-2033 15

3.3 IVD Analyzers Market, North America, Volume (Units), 2018-2033 17

3.4 IVD Analyzers Market, North America, Volume (Units), 2018-2033 18

3.5 IVD Analyzers Market, North America, Company Share by Revenue ($m), 2024 20

4 IVD Analyzers Market, Canada 22

4.1 IVD Analyzers Market, Canada, Revenue ($m), 2018-2033 22

4.1.1 Clinical Chemistry Analyzers Market, Canada, Revenue ($m), by Segment, 2018-2033 24

4.1.2 Hematology Analyzers Market, Canada, Revenue ($m), by Segment, 2018-2033 26

4.1.3 Immunochemistry Analyzers Market, Canada, Revenue ($m), by Segment, 2018-2033 28

4.1.4 Point of Care (POC) Analyzers Market, Canada, Revenue ($m), by Segment, 2018-2033 30

4.1.5 Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), by Segment, 2018-2033 32

4.2 IVD Analyzers Market, Canada, Volume (Units), 2018-2033 34

4.2.1 Clinical Chemistry Analyzers Market, Canada, Volume (Units), by Segment, 2018-2033 36

4.2.2 Hematology Analyzers Market, Canada, Volume (Units), by Segment, 2018-2033 38

4.2.3 Immunochemistry Analyzers Market, Canada, Volume (Units), by Segment, 2018-2033 40

4.2.4 Point of Care (POC) Analyzers Market, Canada, Volume (Units), by Segment, 2018-2033 42

4.2.5 Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), by Segment, 2018-2033 44

4.3 IVD Analyzers Market, Canada, Average Price ($), 2018-2033 46

4.4 IVD Analyzers Market, Canada, Company Share by Revenue ($m), 2024 49

5 IVD Analyzers Market, United States 51

5.1 IVD Analyzers Market, United States, Revenue ($m), 2018-2033 51

5.1.1 Clinical Chemistry Analyzers Market, United States, Revenue ($m), by Segment, 2018-2033 53

5.1.2 Hematology Analyzers Market, United States, Revenue ($m), by Segment, 2018-2033 55

5.1.3 Immunochemistry Analyzers Market, United States, Revenue ($m), by Segment, 2018-2033 57

5.1.4 Next Generation Sequencers Market, United States, Revenue ($m), by Segment, 2018-2033 59

5.1.5 Point of Care (POC) Analyzers Market, United States, Revenue ($m), by Segment, 2018-2033 61

5.1.6 Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), by Segment, 2018-2033 63

5.2 IVD Analyzers Market, United States, Volume (Units), 2018-2033 65

5.2.1 Clinical Chemistry Analyzers Market, United States, Volume (Units), by Segment, 2018-2033 67

5.2.2 Hematology Analyzers Market, United States, Volume (Units), by Segment, 2018-2033 69

5.2.3 Immunochemistry Analyzers Market, United States, Volume (Units), by Segment, 2018-2033 71

5.2.4 Next Generation Sequencers Market, United States, Volume (Units), by Segment, 2018-2033 73

5.2.5 Point of Care (POC) Analyzers Market, United States, Volume (Units), by Segment, 2018-2033 75

5.2.6 Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), by Segment, 2018-2033 77

5.3 IVD Analyzers Market, United States, Average Price ($), 2018-2033 79

5.4 IVD Analyzers Market, United States, Company Share by Revenue ($m), 2024 82

6 IVD Analyzers Market, Mexico 84

6.1 IVD Analyzers Market, Mexico, Revenue ($m), 2018-2033 84

6.1.1 Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), by Segment, 2018-2033 86

6.1.2 Hematology Analyzers Market, Mexico, Revenue ($m), by Segment, 2018-2033 88

6.1.3 Immunochemistry Analyzers Market, Mexico, Revenue ($m), by Segment, 2018-2033 90

6.1.4 Next Generation Sequencers Market, Mexico, Revenue ($m), by Segment, 2018-2033 92

6.1.5 Point of Care (POC) Analyzers Market, Mexico, Revenue ($m), by Segment, 2018-2033 94

6.1.6 Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), by Segment, 2018-2033 96

6.2 IVD Analyzers Market, Mexico, Volume (Units), 2018-2033 98

6.2.1 Clinical Chemistry Analyzers Market, Mexico, Volume (Units), by Segment, 2018-2033 100

6.2.2 Hematology Analyzers Market, Mexico, Volume (Units), by Segment, 2018-2033 102

6.2.3 Immunochemistry Analyzers Market, Mexico, Volume (Units), by Segment, 2018-2033 104

6.2.4 Next Generation Sequencers Market, Mexico, Volume (Units), by Segment, 2018-2033 106

6.2.5 Point of Care (POC) Analyzers Market, Mexico, Volume (Units), by Segment, 2018-2033 108

6.2.6 Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), by Segment, 2018-2033 110

6.3 IVD Analyzers Market, Mexico, Average Price ($), 2018-2033 113

6.4 IVD Analyzers Market, Mexico, Company Share by Revenue ($m), 2024 116

7 Overview of Key Companies in North America IVD Analyzers Market 118

7.1 Danaher Corp 118

7.1.1 Company Overview 118

7.2 Siemens Healthineers AG 118

7.2.1 Company Overview 118

7.3 F. Hoffmann-La Roche Ltd 118

7.3.1 Company Overview 118

7.4 Abbott Laboratories 119

7.4.1 Company Overview 119

7.5 Sysmex Corp 119

7.5.1 Company Overview 119

7.6 Bio-Rad Laboratories Inc 119

7.6.1 Company Overview 119

7.7 Agilent Technologies Inc 119

7.7.1 Company Overview 119

7.8 Thermo Fisher Scientific Inc 120

7.8.1 Company Overview 120

7.9 Quidelortho Corp 120

7.9.1 Company Overview 120

7.10 Hologic Inc 120

7.10.1 Company Overview 120

8 IVD Analyzers Market Pipeline Products 121

9 Recent Developments 157

9.1 Corporate Communications 157

9.1.1 Apr 23, 2025: Huiyu Pharmaceutical’s Clinical Trial Application for Innovative Biological Drug HY-0005 Has Been Accepted 157

9.1.2 Mar 18, 2025: NeoGenomics Appoints Warren Stone as President & Chief Operating Officer 158

9.1.3 Nov 21, 2024: United Imaging Announces the First of Several New U.S. Product Launches For RSNA 158

9.1.4 Aug 20, 2024: Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer 159

9.2 Financial Announcements 159

9.2.1 Apr 22, 2025: Quest Diagnostics Announces Results for Q1 Ended March 31, 2025 159

9.2.2 Apr 08, 2025: NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025 160

9.2.3 Mar 13, 2025: Zomedica Announces Record Revenue and Strategic Growth in 2024 160

9.2.4 Feb 26, 2025: Zomedica Announces Upcoming Financial Results Conference Call 160

9.2.5 Feb 18, 2025: NeoGenomics Reports Fourth Quarter and Full Year 2024 Results 160

9.2.6 Feb 07, 2025: MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference 161

9.2.7 Jan 29, 2025: NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025 161

9.2.8 Jan 28, 2025: Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call 162

9.2.9 Jan 22, 2025: Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors 162

9.2.10 Jan 10, 2025: Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results 162

9.2.11 Oct 25, 2024: Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results 163

9.2.12 Oct 16, 2024: Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors 163

9.2.13 Oct 16, 2024: Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call 163

9.2.14 Sep 24, 2024: Labcorp to Announce Third Quarter Financial Results on October 24, 2024 163

9.2.15 Aug 13, 2024: Syntec Optics to Host Conference Call to Discuss Financial Results and Business Update 164

9.2.16 Aug 08, 2024: Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results 164

9.2.17 Aug 06, 2024: MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance 164

9.2.18 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors 165

9.2.19 Jul 09, 2024: NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024 166

9.2.20 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings 166

9.3 Government and Public Interest 166

9.3.1 Feb 24, 2025: NeoGenomics to Participate in Upcoming Investor Conferences 166

9.3.2 Feb 17, 2025: Baxter to Present at Raymond James & Associates’ 46th Annual Institutional Investors Conference 166

9.3.3 Feb 07, 2025: MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference 166

9.3.4 Dec 18, 2024: Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference 167

9.3.5 Nov 12, 2024: Baxter to Present at Stifel 2024 Healthcare Conference 167

9.3.6 Aug 29, 2024: NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference 167

9.3.7 Aug 28, 2024: Baxter to Present at 2024 Wells Fargo Healthcare Conference 167

9.4 Legal And Regulatory 167

9.4.1 Jun 19, 2025: CnS Medical Receives 510(K) Clearance For DELPHI System 167

9.4.2 Jun 05, 2025: Sonoma Biotherapeutics Announces Poster Presentation at the 2025 European Alliance of Associations for Rheumatology (EULAR) Congress 168

9.4.3 Mar 19, 2025: Sonnet Receives Notice of Allowance for U.S. Patent Covering Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein 168

9.4.4 Mar 07, 2025: Medtronic Neuromodulation Received Humanitarian Device Exemption (HDE) For Percept PC BrainSense Neurostimulator Model – B35200 169

9.4.5 Jan 13, 2025: VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025 169

9.4.6 Dec 18, 2024: Howmedica Osteonics Receives Additional 510(K) Clearance For AVON Patello-Femoral Joint Prosthesis 171

9.4.7 Dec 18, 2024: Positive Results Advance Peanut Tablet to Phase II Development 171

9.4.8 Dec 10, 2024: Enterome’s EO2463 Shows Early Clinical Response in Newly Diagnosed Follicular Lymphoma Suggesting a Potential Alternative to ‘Watchful Waiting 172

9.4.9 Nov 19, 2024: Botanix presentation at Bell Potter Healthcare Conference 174

9.4.10 Oct 08, 2024: Microport Medbot Skywalker Orthopedic Surgical Robot Gets Approval in Japan 174

9.4.11 Sep 26, 2024: Personalised Energy Expenditure Data Enhances Weight Loss in Obesity: New Study Findings 175

9.5 Other Significant Developments 176

9.5.1 Apr 30, 2025: AdjuTec Pharma’s APC148 Shines at ESCMID Congress 176

9.5.2 Feb 05, 2025: UMC Utrecht Adopts Volta Labs Callisto Sample Prep System to Process Thousands of Samples for Whole Genome Sequencing-Based Prenatal and Postnatal Testing 176

9.5.3 Oct 24, 2024: Fisher Scientific Donates $150,000 in Equipment and Supplies to New Toxicology Centre Lab 177

9.6 Product News 177

9.6.1 May 28, 2025: Waters Launches BioResolve Protein A Affinity Columns 177

9.6.2 May 22, 2025: Thermo Fisher Scientific Unveils Next Generation TruNarc Handheld Narcotics Analyzers to Support Public Safety 178

9.6.3 May 06, 2025: DCN Dx Launches Redesigned Website to Improve Access to Resources, Showcase Team 179

9.6.4 Apr 24, 2025: Isolere Bio by Donaldson Passes Most Significant Milestone To-Date, Announces Availability of Manufacturing-Grade IsoTag AAV Reagent 179

9.6.5 Apr 22, 2025: Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development 180

9.6.6 Apr 01, 2025: Waters Announces Expansion of Alliance iS Bio HPLC Product Line 181

9.6.7 Mar 03, 2025: BrightSpec Launches World's First Commercial MRR Instruments in 50 Years at PittCon 2025 182

9.6.8 Jan 24, 2025: Curiox Biosystems Launches Curiox C- Free Pluto ALPHA: Affordable, Hassle-Free Cell Washing Automation 183

9.6.9 Jan 22, 2025: Targeted Bioscience Unveils Revolutionary Extracellular Vesicle Isolation Kit 183

9.6.10 Jan 15, 2025: RID Launches a One-Button Solution for Microbiology Testing That Provides Pathogen ID and Antibiotic Sensitivity in 5 Hours 184

9.6.11 Dec 02, 2024: Bruker Announces Launch of Dimension Nexus Atomic Force Microscope 184

9.6.12 Nov 07, 2024: Waters New Software Delivers Lab-Centric Business Intelligence and Enables Confident Audit-Readiness 185

9.6.13 Oct 17, 2024: Charles River Launches New Retrogenix Non-human Protein Library 185

9.6.14 Oct 14, 2024: BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research 186

9.6.15 Oct 03, 2024: Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024 187

9.6.16 Oct 01, 2024: Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity 188

9.6.17 Sep 17, 2024: Charles River Comparative Study Reveals that Kytopen's Flowfect Tx Platform Outperforms Conventional Electroporation Platforms 188

9.6.18 Aug 29, 2024: Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine 189

9.6.19 Aug 14, 2024: Bruker Announces Successful Installation of

1.2 GHz Avance NMR Spectrometer at the Korea Basic Science Institute (KBSI) 191

9.6.20 Aug 07, 2024: Bio-Rad Launches Annexin V StarBright Conjugates for Apoptosis Detection via Flow Cytometry 192

9.6.21 Jul 25, 2024: Thermo Fisher Scientific Showcases Diagnostics Innovation Across Therapeutic Areas at ADLM 2024 192

9.6.22 Jun 27, 2024: Nikon Introduces Newly Developed Imaging Technology for Greatly Accelerated Speed and Efficiency in Research for Biotechnology 194

9.6.23 Jun 27, 2024: Zomedica Expands Truforma Addressable Market with Launch of Equine Cortisol Assay for the Platform 194

9.7 Strategy And Business Planning 195

9.7.1 May 13, 2025: Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics 195

9.7.2 Apr 25, 2025: Bioskryb Genomics and Tecan Introduce a Single-Cell Multiomics Workflow for Sequencing-Ready Libraries in Under Ten Hours 195

9.7.3 Feb 28, 2025: BioChain Announces Strategic Partnership With Spatomics 196

9.7.4 Oct 02, 2024: Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica to Advance the Discovery of Novel Drugs for Neurological Disease 196

9.7.5 Sep 23, 2024: Angle PLC Announces Exclusive Agreement for DNA NGS Panel 197

9.7.6 Sep 14, 2024: RYBREVANT (Amivantamab) Plus Chemotherapy Show 49 Percent Overall Response Rate in Metastatic Colorectal Cancer 197

9.7.7 Jul 01, 2024: Artel Portfolio Expands Presence in Europe 199

9.7.8 Jun 25, 2024: Curiox Biosystems Announces the Establishment of the Curiox Innovation Center for the Curiox C-FREE Pluto LT System at Stanford University's Human Immune Monitoring Center 200

10 Appendix 201

10.1 Research Methodology 202

10.1.1 Coverage 202

10.1.2 Secondary Research 202

10.1.3 Primary Research 202

10.1.4 Market Modeling and Forecasting 203

10.1.5 Company Share Analysis 204

10.1.6 Benchmarking 205

10.2 GlobalData Consulting 206

10.3 Contact Us 206

10.4 Disclaimer 206

 

Table

Table 1: IVD Analyzers Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 14

Table 2: IVD Analyzers Market, North America, Revenue ($m), USD Constant, 2018-2033 16

Table 3: IVD Analyzers Market, North America, Volume (Units), 2018-2033 17

Table 4: IVD Analyzers Market, North America, Volume (Units), 2018-2033 19

Table 5: IVD Analyzers Market, North America, Company Share by Revenue ($m), 2024 21

Table 6: IVD Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 23

Table 7: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 25

Table 8: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 27

Table 9: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 29

Table 10: Point of Care (POC) Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 31

Table 11: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, 2018-2033 33

Table 12: IVD Analyzers Market, Canada, Volume (Units), 2018-2033 35

Table 13: Clinical Chemistry Analyzers Market, Canada, Volume (Units), 2018-2033 37

Table 14: Hematology Analyzers Market, Canada, Volume (Units), 2018-2033 39

Table 15: Immunochemistry Analyzers Market, Canada, Volume (Units), 2018-2033 41

Table 16: Point of Care (POC) Analyzers Market, Canada, Volume (Units), 2018-2033 43

Table 17: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), 2018-2033 45

Table 18: IVD Analyzers Market, Canada, Average Price ($), 2018-2033 46

Table 19: IVD Analyzers Market, Canada, Company Share by Revenue ($m), 2024 50

Table 20: IVD Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 52

Table 21: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 54

Table 22: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 56

Table 23: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 58

Table 24: Next Generation Sequencers Market, United States, Revenue ($m), USD Constant, 2018-2033 60

Table 25: Point of Care (POC) Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 62

Table 26: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 64

Table 27: IVD Analyzers Market, United States, Volume (Units), 2018-2033 66

Table 28: Clinical Chemistry Analyzers Market, United States, Volume (Units), 2018-2033 68

Table 29: Hematology Analyzers Market, United States, Volume (Units), 2018-2033 70

Table 30: Immunochemistry Analyzers Market, United States, Volume (Units), 2018-2033 72

Table 31: Next Generation Sequencers Market, United States, Volume (Units), 2018-2033 74

Table 32: Point of Care (POC) Analyzers Market, United States, Volume (Units), 2018-2033 76

Table 33: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), 2018-2033 78

Table 34: IVD Analyzers Market, United States, Average Price ($), 2018-2033 79

Table 35: IVD Analyzers Market, United States, Company Share by Revenue ($m), 2024 83

Table 36: IVD Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 85

Table 37: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 87

Table 38: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 89

Table 39: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 91

Table 40: Next Generation Sequencers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 93

Table 41: Point of Care (POC) Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 95

Table 42: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, 2018-2033 97

Table 43: IVD Analyzers Market, Mexico, Volume (Units), 2018-2033 99

Table 44: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), 2018-2033 101

Table 45: Hematology Analyzers Market, Mexico, Volume (Units), 2018-2033 103

Table 46: Immunochemistry Analyzers Market, Mexico, Volume (Units), 2018-2033 105

Table 47: Next Generation Sequencers Market, Mexico, Volume (Units), 2018-2033 107

Table 48: Point of Care (POC) Analyzers Market, Mexico, Volume (Units), 2018-2033 109

Table 49: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), 2018-2033 111

Table 50: IVD Analyzers Market, Mexico, Average Price ($), 2018-2033 113

Table 51: IVD Analyzers Market, Mexico, Company Share by Revenue ($m), 2024 117

Table 52: IVD Analyzers Market Pipeline Products 121

Table 53: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 203

Figures

Figure 1: IVD Analyzers Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 14

Figure 2: IVD Analyzers Market, North America, Revenue ($m), USD Constant, 2018-2033 15

Figure 3: IVD Analyzers Market, North America, Volume (Units), 2018-2033 17

Figure 4: IVD Analyzers Market, North America, Volume (Units), 2018-2033 18

Figure 5: IVD Analyzers Market, North America, Company Share (%), 2024 20

Figure 6: IVD Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 22

Figure 7: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 24

Figure 8: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 26

Figure 9: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 28

Figure 10: Point of Care (POC) Analyzers Market, Canada, Revenue ($m), USD Constant, 2018-2033 30

Figure 11: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, 2018-2033 32

Figure 12: IVD Analyzers Market, Canada, Volume (Units), 2018-2033 34

Figure 13: Clinical Chemistry Analyzers Market, Canada, Volume (Units), 2018-2033 36

Figure 14: Hematology Analyzers Market, Canada, Volume (Units), 2018-2033 38

Figure 15: Immunochemistry Analyzers Market, Canada, Volume (Units), 2018-2033 40

Figure 16: Point of Care (POC) Analyzers Market, Canada, Volume (Units), 2018-2033 42

Figure 17: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), 2018-2033 44

Figure 18: IVD Analyzers Market, Canada, Company Share (%), 2024 49

Figure 19: IVD Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 51

Figure 20: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 53

Figure 21: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 55

Figure 22: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 57

Figure 23: Next Generation Sequencers Market, United States, Revenue ($m), USD Constant, 2018-2033 59

Figure 24: Point of Care (POC) Analyzers Market, United States, Revenue ($m), USD Constant, 2018-2033 61

Figure 25: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 63

Figure 26: IVD Analyzers Market, United States, Volume (Units), 2018-2033 65

Figure 27: Clinical Chemistry Analyzers Market, United States, Volume (Units), 2018-2033 67

Figure 28: Hematology Analyzers Market, United States, Volume (Units), 2018-2033 69

Figure 29: Immunochemistry Analyzers Market, United States, Volume (Units), 2018-2033 71

Figure 30: Next Generation Sequencers Market, United States, Volume (Units), 2018-2033 73

Figure 31: Point of Care (POC) Analyzers Market, United States, Volume (Units), 2018-2033 75

Figure 32: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), 2018-2033 77

Figure 33: IVD Analyzers Market, United States, Company Share (%), 2024 82

Figure 34: IVD Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 84

Figure 35: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 86

Figure 36: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 88

Figure 37: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 90

Figure 38: Next Generation Sequencers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 92

Figure 39: Point of Care (POC) Analyzers Market, Mexico, Revenue ($m), USD Constant, 2018-2033 94

Figure 40: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, 2018-2033 96

Figure 41: IVD Analyzers Market, Mexico, Volume (Units), 2018-2033 98

Figure 42: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), 2018-2033 100

Figure 43: Hematology Analyzers Market, Mexico, Volume (Units), 2018-2033 102

Figure 44: Immunochemistry Analyzers Market, Mexico, Volume (Units), 2018-2033 104

Figure 45: Next Generation Sequencers Market, Mexico, Volume (Units), 2018-2033 106

Figure 46: Point of Care (POC) Analyzers Market, Mexico, Volume (Units), 2018-2033 108

Figure 47: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), 2018-2033 110

Figure 48: IVD Analyzers Market, Mexico, Company Share (%), 2024 116

North America IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others in real time.

  • Access a live North America IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more